We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

Back to rankings

1 hedge funds and large institutions have $65K invested in Loxo Oncology, Inc in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 231 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 232 → 1 (-231)

100% less funds holding in top 10

Funds holding in top 10: 7 → 0 (-7)

100% less capital invested

Capital invested by funds: $4.15B → $65K (-$4.15B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 231

Holders
1
Holders Change
-231
Holders Change %
-99.57%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
231
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$391M
2
BlackRock
BlackRock
New York
-$319M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$296M
4
AC
Aisling Capital
New York
-$286M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$280M
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
26
Driehaus Capital Management
Illinois
– -$35.6M -254,274 Closed
PAMU
27
Pictet Asset Management (UK)
United Kingdom
– -$34K -242,855 Closed
RSCM
28
Rock Springs Capital Management
Maryland
– -$33.8M -241,500 Closed
Franklin Resources
29
Franklin Resources
California
– -$33.7M -240,609 Closed
Goldman Sachs
30
Goldman Sachs
New York
– -$32.6M -232,815 Closed
Lord, Abbett & Co
31
Lord, Abbett & Co
New Jersey
– -$31.1M -221,673 Closed
Brown Advisory
32
Brown Advisory
Maryland
– -$30.4M -217,323 Closed
Millennium Management
33
Millennium Management
New York
– -$30M -214,514 Closed
Charles Schwab
34
Charles Schwab
California
– -$29M -207,124 Closed
CS
35
Candriam SCA
Luxembourg
– -$28.1M -200,673 Closed
Alkeon Capital Management
36
Alkeon Capital Management
New York
– -$28M -199,967 Closed
MWNA
37
Marshall Wace North America
New York
– -$27M -193,114 Closed
VOYA Investment Management
38
VOYA Investment Management
Georgia
– -$25.7M -183,194 Closed
DCM
39
DAFNA Capital Management
California
– -$25.4M -181,675 Closed
OM
40
Opaleye Management
Massachusetts
– -$24.5M -175,000 Closed
UBS AM
41
UBS AM
Illinois
– -$22.6M -161,515 Closed
EA
42
Emerald Advisers
Pennsylvania
– -$21.6M -154,416 Closed
CS
43
Credit Suisse
Switzerland
– -$20.9M -149,228 Closed
Fiera Capital (Canada)
44
Fiera Capital (Canada)
Quebec, Canada
– -$20.1M -143,735 Closed
EMFAT
45
Emerald Mutual Fund Advisers Trust
Pennsylvania
– -$19.6M -139,619 Closed
HA
46
HHLR Advisors
Cayman Islands
– -$18.4M -131,300 Closed
Bank of New York Mellon
47
Bank of New York Mellon
New York
– -$17.9M -127,474 Closed
Invesco
48
Invesco
Georgia
– -$16.6M -118,310 Closed
JP Morgan Chase
49
JP Morgan Chase
New York
– -$14.1M -100,728 Closed
BNP Paribas Asset Management
50
BNP Paribas Asset Management
France
– -$12.2M -90,971 Closed
1
2
3 4 5

LOXO Hedge Fund Activity: Q1 2019 in Review

1 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q1 2019, worth a combined $65K — down 100% from $4.15B a quarter earlier.

Sellers outnumbered buyers: 231 funds closed out of LOXO and 0 opened new positions — a net loss of 231 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $391M sold.

  • 1 institutional investor held Loxo Oncology, Inc (LOXO) as of Q1 2019, down from 232 in Q4 2018.
  • Funds reported $65K of Loxo Oncology, Inc stock for Q1 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Loxo Oncology, Inc positions in Q1 2019 and 231 closed out, a net change of -231 holders.
  • The largest Loxo Oncology, Inc seller in Q1 2019 was Vanguard Group, an estimated $391M sold.

Based on aggregated 13F filings for Q1 2019.